首页 | 本学科首页   官方微博 | 高级检索  
     


Anaphylactic shock depends on endothelial Gq/G11
Authors:Hanna Korhonen, Beate Fisslthaler, Alexandra Moers, Angela Wirth, Daniel Habermehl, Thomas Wieland, Gü  nther Schü  tz, Nina Wettschureck, Ingrid Fleming,   Stefan Offermanns
Affiliation:Hanna Korhonen, Beate Fisslthaler, Alexandra Moers, Angela Wirth, Daniel Habermehl, Thomas Wieland, Günther Schütz, Nina Wettschureck, Ingrid Fleming, and Stefan Offermanns
Abstract:Anaphylactic shock is a severe allergic reaction involving multiple organs including the bronchial and cardiovascular system. Most anaphylactic mediators, like platelet-activating factor (PAF), histamine, and others, act through G protein–coupled receptors, which are linked to the heterotrimeric G proteins Gq/G11, G12/G13, and Gi. The role of downstream signaling pathways activated by anaphylactic mediators in defined organs during anaphylactic reactions is largely unknown. Using genetic mouse models that allow for the conditional abrogation of Gq/G11- and G12/G13-mediated signaling pathways by inducible Cre/loxP-mediated mutagenesis in endothelial cells (ECs), we show that Gq/G11-mediated signaling in ECs is required for the opening of the endothelial barrier and the stimulation of nitric oxide formation by various inflammatory mediators as well as by local anaphylaxis. The systemic effects of anaphylactic mediators like histamine and PAF, but not of bacterial lipopolysaccharide (LPS), are blunted in mice with endothelial Gαq/Gα11 deficiency. Mice with endothelium-specific Gαq/Gα11 deficiency, but not with Gα12/Gα13 deficiency, are protected against the fatal consequences of passive and active systemic anaphylaxis. This identifies endothelial Gq/G11-mediated signaling as a critical mediator of fatal systemic anaphylaxis and, hence, as a potential new target to prevent or treat anaphylactic reactions.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号